WayneBHarrisMD

Oncology • Atlanta, GA

Genitourinary Oncology, Hematologic Oncology

Associate Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine Assistant Chief of Hematology and Medical Oncology, Atlanta Veterans Affairs Medical Center

Join to view full profile

Dr. Harris is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Harris' full profile

Already have an account?

Office
1365 Clifton Rd NE
Atlanta, GA 30322
Phone+1 404-778-5000

Education & Training

Emory University School of MedicineFellowship, Hematology and Medical Oncology, 1995 - 1998
Emory University School of MedicineResidency, Internal Medicine, 1988 - 1991
Loma Linda University School of MedicineClass of 1988

Certifications & Licensure

GA State Medical License 1991 - 2025
TN State Medical License 1991 - 1995
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Board of Trustees Loma Linda University Health, 2016

Clinical Trials

177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer Start of enrollment: 2009 Jun 01
Active, not recruiting
Phase 2
A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer Start of enrollment: 2011 Sep 06
Completed
Phase 1, Phase 2
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery Start of enrollment: 2012 Jun 12
Active, not recruiting
Phase 2, Phase 3
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery Start of enrollment: 2012 Aug 08
Active, not recruiting
Phase 3
S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer Start of enrollment: 2013 Mar 08
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

13 citations
Post-ischemic stroke systemic inflammation: Immunomodulation by progesterone and vitamin D hormone.
Fahim Atif, Seema Yousuf, Claudia Espinosa-Garcia, Wayne Harris, Donald G. Stein
Neuropharmacology. 2020-09-18
102 citations
Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies.
Daruka Mahadevan, E. G. Chiorean, Wayne Harris, D. D. Von Hoff, A. Stejskal-Barnett
European Journal of Cancer. 2012-12-01
37 citations
The Toll-like receptor 5 agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an NK cell-dependent mechanism
Hua Yang, Craig M. Brackett, Vanessa M. Morales-Tirado, Zezhong Li, Qing Zhang
Oncotarget. 2016-01-19

Press Mentions

Prostate Cancer Risk Greatest in African American MenJanuary 24th, 2024

Professional Memberships

Other Languages

Spanish, Portuguese